동반진단 제휴 및 라이선싱 계약(2010-2026년)

The definitive benchmark for companion diagnostic dealmaking

Companion diagnostic partnering is driven by the integration of diagnostics with therapeutic development, with deal structures reflecting co-development strategies, regulatory alignment, and precision medicine approaches.

This report provides a comprehensive and structured analysis of 560+ companion diagnostic collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how companion diagnostic deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by technology type, therapeutic alignment, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a precision medicine-driven and co-development-focused landscape
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark diagnostic-therapeutic partnerships
• Prepare for negotiations with well-defined market context
• Evaluate co-development and licensing opportunities
• Support internal strategy with robust, defensible data
• What's included
• 560+ companion diagnostic collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, technology, and therapeutic alignment)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for companion diagnostic dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how companion diagnostic partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in companion diagnostic dealmaking

• 2.1. Introduction
• 2.2. Companion diagnostic deals over the years
• 2.3. Most active companion diagnostic dealmakers
• 2.4. Companion diagnostic deals by deal type
• 2.5. Companion diagnostic deals by therapy area
• 2.6. Companion diagnostic deals by industry sector
• 2.7. Deal terms for companion diagnostic deals
  • 2.7.1 Companion diagnostic deals headline values
  • 2.7.2 Companion diagnostic deal upfront payments
  • 2.7.3 Companion diagnostic deal milestone payments
  • 2.7.4 Companion diagnostic royalty rates

Chapter 3 - Leading companion diagnostic deals

• 3.1. Introduction
• 3.2. Top companion diagnostic deals by value

Chapter 4 - Most active companion diagnostic dealmakers

• 4.1. Introduction
• 4.2. Most active companion diagnostic dealmakers
• 4.3. Most active companion diagnostic deals company profiles

Chapter 5 - Companion diagnostic contracts dealmaking directory

• 5.1. Introduction
• 5.2. Companion diagnostic contracts dealmaking directory

Chapter 6 - Companion diagnostic dealmaking by technology type

• Deal directory
• Deal directory - Companion diagnostic deals by company A-Z
• Deal directory - Companion diagnostic deals by deal type
• Deal directory - Companion diagnostic deals by therapy area
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Companion diagnostic deals since 2016
• Figure 2: Active companion diagnostic dealmaking activity since 2016
• Figure 3: Companion diagnostic deals by deal type since 2016
• Figure 4: Companion diagnostic deals by therapy area since 2016
• Figure 5: Companion diagnostic deals by industry sector since 2016
• Figure 6: Companion diagnostic deals with a headline value
• Figure 7: Companion diagnostic deals with an upfront value
• Figure 8: Companion diagnostic deals with a milestone value
• Figure 9: Companion diagnostic deals with a royalty rate value
• Figure 10: Top companion diagnostic deals by value since 2016
• Figure 11: Most active companion diagnostic dealmakerssince 2016
• Figure 12: Companion diagnostic deals by technology type since 2016